Skip to main content
EVEX logo

EVEX · Eve Holding, Inc.

Track EVEX — free
$1.35 -0.04 (-2.88%) At close · Nov 19
Market Cap
$470.47M
Shares
348.50M
Volume · Nov 19 1.58M Avg daily vol (3M) 1.08M

Price & Indicators

 

Key stats

Close
$1.35
Open
$1.40
Day range
$1.27–1.45
52-week closing range
$1.35–5.04
Average volume, 30 days
1.2M
Short interest
15.3M · 4.4% of shares · 12.7 days
Short volume, last session
59%
Last earnings
Nov 5, 2026
Latest filing
10-Q · Nov 5
Price history
May 2022 to Nov 2026

Up next

Mar 16, 2027 Est · unconfirmed · in 17 wks

Latest documents

2026
Nov 5
Earnings call
Cash burn targets low end as transition nears

EVE Holding, Inc. ended the third quarter, 2026 with $356 million cash and $471 million liquidity, expecting $225 million to $275 million cash consumption in 2026 while targeting its first full transition flight by year-end.

3 source passages
EVEN ended the third quarter, 2026, with $356 million in cash and total liquidity of $471 million, which includes $114 million in undrawn standby credit loans. With that, EVE's total cash consumption is now pointing towards the low end of our guidance of $225 million to $275 million in 2026, which is a reduction versus our initial forecast. That phase is now complete, and we plan on performing our first full transition flight by powering the lifter down before the end of the year. Open the document at this passage
Nov 5
Current report 8-K
Net loss widens as 2026 cash consumption nears guidance low end

Eve reported a 3Q26 net loss of $58.1 million, versus $46.9 million in 3Q25. Free cash flow was $55.1 million, cash and financial investments totaled $356.0 million, and total liquidity was $470.4 million; 2026 cash consumption is expected between $225 million and $275 million.

Financial results
5 source passages
Eve reported a net loss of $58.1 million in 3Q26 versus $46.9 million in 3Q25. Eve’s total cash consumption in 3Q26 was $55.1 million – vs. $60.7 million in 3Q25, with intensifying design & development activities. Eve’s Cash, Cash Equivalents, and Financial Investments totaled $356.0 million at the end of 3Q26. Total liquidity – including undrawn credit lines with the Brazil’s National Development Bank (BNDES) and a grant, reached $470.4 million. Eve expects to consume between $225 million and $275 million in 2026. Open the document at this passage
Nov 5
Quarterly report 10-Q FY2026 Q3, ended Sep 30
eVTOL commercialization targeted for 2028 with $470.4 million liquidity

Eve targets eVTOL commercialization in 2028 after completing its 50th test flight in April 2026. As of September 30, 2026, it had approximately $470.4 million of liquidity, expected to fund operations for at least the next twelve months.

Net loss $58.05M Diluted EPS -$0.16
Read from the MD&A section
3 source passages
In April 2026, we announced the completion of the 50th test flight of our uncrewed full-scale eVTOL aircraft prototype. Based on the current expected timeline for obtaining certain authorizations and certifications related to the production of our eVTOL and the deployment of our related services, we currently anticipate commercialization of our eVTOL and our eVTOL services-and-support business beginning in 2028. As of September 30, 2026, the Company has cash, cash equivalents and restricted cash of $127.6 million, financial investments of $228.4 million, available debt to be drawn of $104.2 million and grant funding commitments of $10.2 million from Finep, which totals approximately $470.4 million of liquidity. Total liquidity is expected to be sufficient to fund our operating plan for at least the next twelve months. Open the document at this passage
Oct 26
Current report 8-K Events of Oct 21
NYSE to delist Eve warrants and suspend trading over low price

The New York Stock Exchange determined to commence proceedings to delist the company's EVEXW warrants and immediately suspend their trading due to abnormally low selling price levels. Trading in the company's common stock under the symbol EVEX will continue on the NYSE.

Delisting notice or listing transfer
2 source passages
the NYSE has determined to (a) commence proceedings to delist the Company’s public warrants which are traded under the ticker symbol “EVEXW” (the “Warrants”), and (b) immediately suspend trading in the Warrants due to “abnormally low selling price” levels Trading in the Company’s common stock will be unaffected by the delisting of the Warrants and will continue on the NYSE under the symbol “EVEX,” Open the document at this passage
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
−$225.01M
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-42.5%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$25.64M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+7.9%
Year over year · more shares
Price change (1Y)
-65.1%
Trailing year
Short interest
4.4%
Latest settlement · 12.7 days to cover
View all 125 metrics

AI Brief

Q2 FY26 earnings call · Aug 4, 2026
Q2 FY26

TL;DR. Eve reported Q2 2026 with resumed flight testing that included the start of partial transition (pusher engaged, ~30 knots), a ~2,700 aircraft / ~$13.5B pre-order backlog with two new LOIs from Farnborough, $403M cash and $531M total liquidity described as sufficient through 2028, and certification progress with ANAC including a new airworthiness consultation and proposed noise criteria.

Bullish
  • + Prototype resumed flight testing and began partial transition, reaching ~1,200 RPM pusher and ~30 knots forward speed
  • + Q2 ended with $403M cash and $531M total liquidity, described as sufficient to fund operations through 2028 without new funding
  • + R&D of $29M in Q2 was lower than ~$55M in prior quarters due to better supplier agreements and program updates
  • + Identified $100M-$150M of potential synergies with Embraer over three years, with synergies already being captured
Bearish
  • − Q2 net loss of $34M, with full-year 2026 cash consumption still guided to ~$225M-$275M

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Bearish Fundamentals Poor Quant / Vol Very High
Market backdrop VIX 28.4 · fear Equity put/call 0.72
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −46%
below
Price vs 50-day avg −24%
below
RSI (14) 35
neutral
MACD trend Negative
52-week position 0%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −18%
trailing
6-month return −61%
trailing
YTD return −66%
this year
Relative strength −55%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow Distributing
-7% holders QoQ · +20 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
4.39% of shares out · ▲ +6.1% MoM · 12.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
143 holders — mid 3-yr range
Squeeze score 59
elevated · 0–100
Fundamentals
Poor
EPS growth −46%
Y/Y
Free cash flow $-173.0M
Balance sheet $76.6M
net debt
Quant / Vol
risk profile
Very High
Volatility 72%
annualized · 1-yr
Max drawdown −73%
past year
ATR 11.5%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Nov 5, 2026
Total cash consumption · 2026 Maintained $225M – $275M
Aug 4, 2026 $225M – $275M changed to Nov 5, 2026 $225M – $275M
Previous outlook earlier release · from the Earnings Call filed Aug 4, 2026

Still-open targets the latest release did not restate under the same label.

Research and development expense · going forward (per quarter) $50M
CapEx investments · this year (2026) $20M
CapEx investments · next year (2027) $50M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−46% Bearish
Price vs 50-day avg
−24% Bearish
RSI (14)
35 Neutral
MACD trend
Negative Bearish
52-week position
0% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow Distributing
-7% holders QoQ · +20 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
4.39% of shares out · ▲ +6.1% MoM · 12.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
143 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1 Now $1 · 0% Range high $5
vs 200-day avg -46% vs 50-day avg -24%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Accumulated rig test hours 16,500 current —
Cash consumption $173.1M first nine months of the year —
Cash, Cash Equivalents, Financial Investments (End of period) $356M 3Q26 —
Client base (customers) 28 current —
Engineering prototype flights completed 73 to date in flight campaign —
Free Cash Flow non-GAAP -$55.1M 3Q26 —
Full-scale prototype flights completed 70 current —
LOIs for eVTOLs from TechCare service customers 1.1K current —
Non-binding backlog value 12.6B current —
Non-binding service contracts (customers) 13 current —
Order pipeline 2.5K current —
Share of order book from TechCare service customers 42% current —
Share of planned flight campaign check points validated 91% to date in flight campaign —
Total Liquidity non-GAAP $470.4M Sept. 30, 2026 —
Total liquidity including BNDES Standby Facility and grant non-GAAP $470.4M 3Q26 —
Validated check points 170 to date in flight campaign —
Vector LOI customers 21 current —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Aerospace & Defense — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
EVEX
Eve Holding, Inc.
this stock
$470.47M -66.2% — — 4.4%
SPCX
Space Exploration Technologies Corp
$1.88T — — — 1.0%
GE
General Electric Co
$329.52B +3.5% +18.5% 36.8 1.2%
RTX
RTX Corp
$261.04B +5.5% +17.1% 31.4 1.0%
EADSF
Airbus SE
$170.09B -7.7% — — 0.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
143
% held
13.7%
Net QoQ
+409.3K sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
97
View
Short & Settlement
Short Interest Rising
Shares short
15.3M
Days to cover
12.7d
Change
+877.4K sh
View
Short Volume
Short vol %
59%
As of
Nov 19, 2026
Short Total
View
Fails to Deliver
FTD shares
4.2K
Value
$6.7K
As of
Oct 27, 2026
View
Off-Exchange
Off-exchange %
43.5%
Week of
Oct 12, 2026
Off-exch Lit
View
Financials
Financials
Net income (FY)
$-224.3M
EPS diluted
$-0.70
View
Filings
SEC Filings
Latest
8-K
Filed
Nov 5, 2026
This year
15

Eve reported a 3Q26 net loss of $58.1 million, versus $46.9 million in 3Q25. Free cash flow was $55.1 million, cash and financial investments totaled $356.0 million, and total liquidity was $470.4 million; 2026 cash consumption is expected between $225 million and $275 million.

View
Earnings & Events
Webcasts
Last webcast
Nov 5, 2026
View
Investor Relations
Latest news
Eve Air Mobility Technology Suppo…
Published
Nov 13, 2026
View

Performance

5D 20D 120D MTD YTD
EVEX -23.7% -17.7% -60.5% -9.4% -66.2%
SPY -5.5% -6.3% -5.6% -5.3% +5.0%
vs SPY -18.3% -11.4% -54.9% -4.1% -71.2%
Key facts CIK 1823652 CUSIP 29970N104 13F (30d) 151 filings 135 filers Visit website Investor relations